How to File a Patent in India with the Indian Patent Office: A Practical Guide for Foreign Businesses
To file a patent in India, lodge an application with the Indian Patent Office under the Patents Act 1970, either directly or by entering the national phase from a PCT application. India examines only on request, has no utility-model right, and imposes disclosure duties including information on corresponding foreign applications.
Filing a patent in India follows a familiar shape: you lodge an application, request examination, an examiner reviews it, third parties get windows to object, and a patent is granted. What catches out foreign businesses is the local context rather than the mechanics. India examines patents only when you ask it to, it has no utility-model or short-term patent right to fall back on, and it imposes some specific disclosure duties that have no exact equivalent in many home jurisdictions. This guide walks through the process at the Indian Patent Office, which operates under the Controller General of Patents, Designs and Trade Marks (CGPDTM) and is governed by the Patents Act 1970 and its Rules, and explains where the genuine risks sit. It is general information, not legal advice. For anything fact-specific, including patentability of a particular invention or a disclosure question, consult a vetted local firm.
Who can apply
Any person, whether an individual or a legal entity, can apply for a patent in India, either alone or jointly, as the true and first inventor, an assignee, or a legal representative. There is no requirement to have a business presence in India before filing, and foreign applicants are treated on the same statutory footing as domestic ones.
The practical constraint for foreign applicants is representation and address for service. The firm statutory point is that an applicant without a residence or place of business in India must provide an address for service in India for correspondence with the office. Separately, as a practical matter, foreign applicants ordinarily engage a registered Indian patent agent to prosecute the application, since handling the office's procedural steps from abroad is rarely workable. Agent engagement is therefore the normal route rather than itself a statutory precondition to filing, so it is sensible to factor agent engagement into your timeline and budget from the outset, and to confirm the current requirement for your particular circumstances with a local agent.
One structural point is worth internalising early. India has no utility-model or petty-patent system, so there is no quicker, lower-threshold registration route for incremental inventions of the kind some jurisdictions offer. If your invention does not meet the standard patentability thresholds, India does not provide a softer alternative right, which makes getting the patent specification and claims right at the outset more important than in systems with a utility-model safety net.
What can be patented, and the exclusions that surprise applicants
India applies the usual requirements of novelty, inventive step, and industrial applicability. What surprises foreign applicants is the breadth of the statutory exclusions. The Patents Act 1970 sets out categories that are not inventions for the purposes of the Act, and several of them are interpreted more strictly than applicants expect from their home practice.
Software and computer programs, business methods, mathematical methods, and algorithms face well-known limits, and the treatment of computer-implemented inventions is its own specialist topic. Methods of medical treatment are excluded. There are also provisions, often discussed in the context of pharmaceuticals, that constrain patents on new forms of known substances unless enhanced efficacy is shown; the precise scope of this restriction, including what counts as enhanced efficacy, is defined by Indian case law that continues to develop, so it is a specialist question rather than a fixed rule. The point here is not to summarise the case law, which moves, but to flag that an invention readily patentable elsewhere may meet a harder exclusion in India. Where your invention sits anywhere near these boundaries, this is exactly the kind of question to put in front of a vetted local firm before you spend on filing.
Searching and clearance before you file
India does not require a search before filing, but proceeding without one is a false economy. The office examines applications for novelty and inventive step against prior art, and a conflicting earlier disclosure is a common ground for objection. A pre-filing search lets you assess that risk and shape your claims accordingly.
Official and public databases allow a prior-art search, and a professional search through a local agent adds interpretation that a raw database lookup cannot. Search results are a snapshot and do not guarantee grant, because prior art surfaces from many sources and examiner judgement varies. Treat a search as risk assessment, not a green light. Where the result is ambiguous, that ambiguity is itself useful information to take to qualified counsel.
The foreign-filing licence trap for inventions made in India
This is the single point most likely to catch out a foreign business with an Indian connection, so it gets its own heading. Under the Patents Act 1970, where an invention is made in India, there are restrictions on filing a patent application for it abroad first. In broad terms, a person resident in India generally must either file in India first, or obtain written permission (a foreign-filing licence) from the Indian Patent Office, before filing that invention abroad. There is commonly a short waiting period after an Indian filing before a foreign filing can proceed without separate permission, but the exact mechanics are version-specific, so confirm the current position rather than relying on any figure here.
Why this bites foreign businesses: if your invention was actually devised by an inventor resident in India, perhaps at an Indian R&D centre, a subsidiary, or through Indian-based contractors, your home-country first filing may have breached this requirement, with potentially serious consequences for the Indian patent. Multinationals with Indian engineering teams are the classic exposure. If any inventor was resident in India when the invention was made, treat the foreign-filing-licence question as a gating item and resolve it with a registered Indian patent agent or qualified local counsel before filing anywhere, since whether a licence is needed shades into a legal-exposure question rather than a purely procedural one.
The application and examination process
A patent application to the Indian Patent Office includes the applicant and inventor details, a specification (provisional or complete) with claims in the complete specification, and supporting forms. You can file a provisional specification to secure a date and follow with a complete specification within the period allowed by the Rules, or file a complete specification at the outset. If you claim Paris Convention priority from an earlier foreign application, you generally must do so within the convention period and provide supporting documents; confirm the current period and document requirements with your agent.
The feature that most distinguishes Indian practice is that substantive examination does not happen automatically. You must file a request for examination within the period set by the Rules, and if you miss that window the application can be treated as withdrawn. After filing, the process broadly runs through these stages.
| Stage | What happens | Typical sequence |
|---|---|---|
| Filing and formalities | Office checks the application is complete and properly formed | Shortly after filing |
| Publication | Application is published, opening it to public inspection | After a set period from filing or priority, unless early publication is requested |
| Request for examination | Applicant must actively request examination within the allowed window | Within the period set by the Rules |
| Substantive examination | Examiner assesses novelty, inventive step, industrial applicability, and exclusions, then issues an examination report | After a valid examination request |
| Response to objections | Applicant replies to the examination report and must put the application in order for grant within the allowed period | Where objections exist |
| Pre-grant opposition | Any person may oppose before grant | After publication and before grant |
| Grant | If objections are met and opposition does not prevent it, the patent is granted | After examination passes |
If the examiner raises objections in the examination report, the applicant must respond and place the application in order for grant within the period set by the Rules. That period is time-sensitive and missing it can cause the application to be deemed abandoned, so do not rely on any figure in this article; confirm the exact current deadline directly with the office or your agent as soon as a report issues.
Disclosure obligations, including Section 8
India imposes disclosure duties that go beyond what some foreign applicants expect, and falling short of them can expose a granted patent to challenge. Two areas deserve attention.
The first is Section 8 of the Patents Act 1970, which requires an applicant to keep the office informed about corresponding applications for the same or substantially the same invention filed in other countries. In broad terms this means filing a statement of those foreign applications and, on request, providing information about their processing abroad, within the periods set by the Rules. This is an ongoing duty during prosecution, not a one-off form, and non-compliance has been a live ground in Indian patent litigation. If you are running a parallel international filing programme, set up a process so your registered Indian patent agent or qualified local counsel is told about developments in corresponding cases as they happen.
The second is the requirement, where relevant, to disclose the source and geographical origin of biological material used in the invention. If your invention draws on biological resources, this disclosure and related access-and-benefit-sharing considerations can apply, and they are a specialist area. The biological-resources disclosure rules and the related access-and-benefit-sharing regime have been amended in recent years, so confirm the current position with local counsel rather than relying on any prior understanding. In both cases the safe course is to brief a local agent fully on the wider patent family and the invention's inputs, so the disclosures are made correctly and on time.
Opposition
India provides for opposition both before and after grant. Pre-grant opposition allows any person to oppose an application after it is published and before the patent is granted, on grounds set out in the Act. It is a relatively accessible mechanism and can delay or prevent grant.
After grant, an interested person can file a post-grant opposition within the period allowed following grant, and granted patents can also be challenged through revocation proceedings. The grounds overlap substantially with the reasons an examiner might refuse an application in the first place, including lack of novelty, lack of inventive step, insufficiency, and the disclosure failures discussed above. Because the deadlines and grounds are specific and time-limited, monitoring publications and acting quickly matters, and a local firm can run watch services and handle filings within the deadlines.
Roughly how long a grant takes
Timelines vary and the office's processing periods have changed materially over the years, particularly as the request-for-examination and expedited-examination rules have evolved, so treat any single figure with caution. Rather than anchor on a number, plan on the basis that grant often takes a considerable time, frequently measured in years, with the wait for examination and the response period making up much of it. The timing depends heavily on when you request examination, which is within your control, and on how many objections or oppositions the application draws. Expedited examination is available in defined circumstances and can shorten the path considerably; applications that draw substantial objections or an opposition take longer.
Do not plan a product launch or an enforcement strategy around an optimistic best case. Because recent rule amendments have shifted these timelines, request examination early if speed matters, and confirm current processing expectations with your agent rather than relying on a fixed figure that may be out of date.
Renewal and maintenance
An Indian patent has a defined term measured from the filing date of the application, and it is maintained by paying renewal fees periodically through that term. Renewal fees generally begin to fall due after the early years of the patent's life and recur on a defined cycle, with a grace period after a missed due date during which renewal is still possible, often on payment of an additional amount. The exact term, the points at which renewal fees fall due, the grace period, and the charges are version-specific, so rather than relying on any fixed figure here, confirm the current renewal schedule and fees directly with the Indian Patent Office or through your agent.
Missing the renewal deadlines risks the patent lapsing. Restoration may be possible within a limited window on defined conditions, but it is not guaranteed and is better avoided. Diarise renewals well ahead, and confirm current renewal periods and fees on the office's official channels or through your agent, as these are version-specific.
Filing directly versus the PCT national-phase route
Foreign businesses generally reach India by one of two routes: a direct national filing through an Indian patent agent, or entry into the Indian national phase from an international application under the Patent Cooperation Treaty (PCT). India is a long-standing PCT member, and the national-phase route is the common way to add India to a wider international patent programme.
Each route has trade-offs. A direct national filing, often used to claim Paris Convention priority from a first filing within the convention period, gives you a clean Indian application from the start. The PCT route lets you defer the cost and decision of entering India while you pursue protection in many countries from a single international application, then enter the Indian national phase within the period set under the treaty and the Rules. That deferral is the main attraction, but the national-phase deadline is a hard date, and missing it generally forfeits the chance to obtain an Indian patent on that invention.
| Factor | Direct national filing | PCT national-phase entry |
|---|---|---|
| Administering route | National filing via Indian agent | Indian national phase from a PCT application |
| Priority basis | Often Paris Convention priority from a first filing | Through the international application |
| Local agent | Required from the start | Required to enter and prosecute the national phase |
| Key deadline | Convention period for claiming priority | National-phase entry deadline, treated as strict |
| Best suited to | India-focused or early single-country filings | Multi-country portfolios filed together |
Whichever route you choose, the Section 8 disclosure duty and, where relevant, the foreign-filing-licence question still apply, so neither route removes the India-specific obligations. For the wider mechanics of the international route, see our overview of the PCT. For the overall picture of patenting in India, see the India patents pillar. For comparison with other markets, see how filing works in China, the United States, the European Union, and Türkiye.
Practical risks a foreign business should know
A handful of risks recur often enough to flag directly. First, the foreign-filing licence: if any inventor was resident in India when the invention was made, resolve the licence question before filing anywhere, because getting this wrong can undermine the Indian patent. Second, the request-for-examination window: examination is not automatic, and missing the request deadline can lose the application entirely, so treat it as a diarised gating step rather than a formality. Third, Section 8 disclosure: keep your Indian agent informed about corresponding foreign applications throughout prosecution, because non-compliance has been used to attack granted patents.
Fourth, the exclusions: software, business methods, methods of medical treatment, and new forms of known substances face stricter limits than in some home jurisdictions, so test patentability early. Fifth, no utility-model fallback: if the standard patent thresholds are not met, India offers no softer alternative right, which raises the stakes on claim drafting. None of these is exotic, but each has caught out well-resourced applicants. Because the consequences are jurisdiction-specific and often turn on facts, the sensible course before filing in India is to consult a vetted local firm to pressure-test patentability, your disclosure obligations, and the foreign-filing-licence position.
This article is general information and not legal or regulated advice. Official requirements, fees, and processing times are set by the Indian Patent Office under the CGPDTM and change over time; always confirm current details on the office's official channels or through qualified local counsel.